Matthias Eiber
Papers
2
Total Citations
51
H-Index
2
About
Dr. Matthias Eiber is a pioneering figure in theranostics and molecular imaging for prostate cancer, whose work has fundamentally reshaped the management of recurrent disease. His research centers on the clinical translation of prostate-specific membrane antigen (PSMA) ligands, bridging the gap between advanced diagnostics and targeted therapy. Dr. Eiber’s major contributions include the development of a novel molecular radio-guidance technology for lymph node dissection, enabling surgeons to precisely locate and remove metastatic lesions that are invisible to conventional imaging. This approach, detailed in his highly cited 2018 study (30 citations), has dramatically improved surgical precision and patient outcomes. His landmark 2016 work on PSMA theranostics (21 citations) demonstrated the seamless integration of PET imaging with subsequent radioguided surgery, establishing a new paradigm for personalized treatment. Through these innovations, Dr. Eiber has not only advanced the field of urologic oncology but also provided a practical, real-time solution for one of prostate cancer’s most challenging clinical scenarios—recurrence after primary therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2